Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer

[1]  M. Luster,et al.  Management Guidelines for Children With Thyroid Nodules and Differentiated Thyroid Cancer , 2018, Pediatrics.

[2]  A. Alzahrani,et al.  Comparison of differentiated thyroid cancer in children and adolescents (≤20 years) with young adults , 2016, Clinical endocrinology.

[3]  AfkhamiMichelle,et al.  Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAFK601E Mutation , 2016 .

[4]  M. Xing,et al.  Uncommon TERT Promoter Mutations in Pediatric Thyroid Cancer. , 2016, Thyroid : official journal of the American Thyroid Association.

[5]  A. Alzahrani,et al.  Absence of somatic mutations of the mTOR gene in differentiated thyroid cancer , 2015, Meta gene.

[6]  M. Luster,et al.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. , 2015, Thyroid : official journal of the American Thyroid Association.

[7]  L. Buchmann,et al.  BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma , 2014, The Laryngoscope.

[8]  R. Paschke,et al.  Somatic mutations in 33 benign and malignant hot thyroid nodules in children and adolescents , 2014, Molecular and Cellular Endocrinology.

[9]  P. Grigsby,et al.  BRAF V600E mutational status in pediatric thyroid cancer , 2014, Pediatric blood & cancer.

[10]  Ajay K. Singh,et al.  Consanguinity in Saudi Arabia: a unique opportunity for pediatric kidney research. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  G. Sassolas,et al.  Thyroid cancers in children, adolescents, and young adults with and without a history of childhood exposure to therapeutic radiation for other cancers. , 2013, Thyroid : official journal of the American Thyroid Association.

[12]  M. Xing,et al.  Molecular pathogenesis and mechanisms of thyroid cancer , 2013, Nature Reviews Cancer.

[13]  M. Hirokawa,et al.  Functional characterization of the novel BRAF complex mutation, BRAFV600delinsYM, identified in papillary thyroid carcinoma , 2013, International journal of cancer.

[14]  Bo Hyun Kim,et al.  Comparison of Clinical Outcomes in Differentiated Thyroid Carcinoma Between Children and Young Adult Patients , 2012, Clinical nuclear medicine.

[15]  H. Schulten,et al.  BRAF mutations in thyroid tumors from an ethnically diverse group , 2012, Hereditary Cancer in Clinical Practice.

[16]  S. Pfister,et al.  Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma , 2011, International journal of cancer.

[17]  F. Vaisman,et al.  Thyroid Carcinoma in Children and Adolescents—Systematic Review of the Literature , 2011, Journal of thyroid research.

[18]  Marina N. Nikiforova,et al.  Molecular genetics and diagnosis of thyroid cancer , 2011, Nature Reviews Endocrinology.

[19]  S. Lacomme,et al.  BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis , 2011, Pathology.

[20]  R. Roskoski,et al.  RAF protein-serine/threonine kinases: structure and regulation. , 2010, Biochemical and biophysical research communications.

[21]  D. Pearson,et al.  Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma , 2009, Oncogene.

[22]  Simion I. Chiosea,et al.  A Novel Complex BRAF Mutation Detected in a Solid Variant of Papillary Thyroid Carcinoma , 2009, Endocrine pathology.

[23]  M. Santoro,et al.  Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinoma. , 2008, The Journal of clinical endocrinology and metabolism.

[24]  M. Fresno,et al.  BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma , 2008, Clinical endocrinology.

[25]  M. Loda,et al.  BRAF(V600E) mutation and the biology of papillary thyroid cancer. , 2008, Endocrine-related cancer.

[26]  Z. Jehan,et al.  Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population. , 2008, The Journal of clinical endocrinology and metabolism.

[27]  Mansour M. Qurachi,et al.  Regional variations in the prevalence of consanguinity in Saudi Arabia. , 2007, Saudi medical journal.

[28]  A. Pinchera,et al.  Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. , 2006, Endocrine-related cancer.

[29]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[30]  M. Xing,et al.  BRAF mutation in thyroid cancer. , 2005, Endocrine-related cancer.

[31]  V. Trovisco,et al.  Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness , 2005, Virchows Archiv.

[32]  D. Barford,et al.  Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF , 2004, Cell.

[33]  M. Nikiforova,et al.  BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. , 2003, The Journal of clinical endocrinology and metabolism.

[34]  P. Ladenson,et al.  BRAF mutation in papillary thyroid carcinoma. , 2003, Journal of the National Cancer Institute.

[35]  Rui Huang,et al.  Comparison of presentation and clinical outcome between children and young adults with differentiated thyroid cancer. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[36]  E. Mazzaferri,et al.  Increasing Incidence of Thyroid Cancer in the United States, 1973–2002Davies L, Welch HG (Dept of Veterans Affairs Med Ctr, White River Junction, Vt; Darmouth Med School, Hanover, NH) JAMA 295:2164–2167, 2006§ , 2007 .

[37]  R. DeLellis.  Pathology and genetics of tumours of endocrine organs , 2004 .

[38]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[39]  C. Dufourmentel.  [THYROID CANCER IN CHILDREN]. , 1965, L'Annee endocrinologique.